‹
›
This content requires a premium subscription.
Please
log in
or
subscribe
to continue.
JACC This Week
Mortality Benefit of Rivaroxaban plus Aspirin in Patients with Chronic Coronary or Peripheral Artery Disease
30
00:00:00
/ 00:14:20
30